6501 - 6525 of 8399 Results
Title
Year
-
OPENTitle: Unraveling the Biologic Basis for Domain-Specific Cognitive DeclineJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 25Issue #: 7Start Page: 741End Page: 743Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2017.04.007Best OA location URL: https://europepmc.org/articles/pmc5870749?pdf=renderCitation Count: 1
-
OPENTitle: Integrated molecular landscape of Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-017-0015-3Best OA location URL: https://www.nature.com/articles/s41531-017-0015-3.pdfCitation Count: 112
-
OPENTitle: Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson’s disease on chromosome 7p15.3Journal Name: neurogeneticsPublisher: Springer Science and Business Media LLCVol: 18Issue #: 3Start Page: 121End Page: 133Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10048-017-0514-8Best OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs10048-017-0514-8.pdfCitation Count: 68
-
OPENTitle: Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson's diseaseJournal Name: Toxicology and Applied PharmacologyPublisher: Elsevier BVVol: 326Issue #:Start Page: 34End Page: 42Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.taap.2017.04.004Best OA location URL: https://europepmc.org/articles/pmc5704913?pdf=renderCitation Count: 13
-
OPENTitle: Neuropsychological Subgroups in Non-Demented Parkinson’s Disease: A Latent Class AnalysisJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 7Issue #: 2Start Page: 385End Page: 395Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-171081Best OA location URL: https://europepmc.org/articles/pmc5548408?pdf=renderCitation Count: 26
-
OPENTitle: Novel conformation‐selective alpha‐synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's diseaseJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 43Issue #: 7Start Page: 604End Page: 620Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/nan.12402Best OA location URL: https://europepmc.org/articles/pmc5632188?pdf=renderCitation Count: 57
-
OPENTitle: Whole transcriptome profiling of the human hippocampus suggests an involvement of the KIBRA rs17070145 polymorphism in differential activation of the MAPK signaling pathwayJournal Name: HippocampusPublisher: WileyVol: 27Issue #: 7Start Page: 784End Page: 793Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hipo.22731Best OA location URL: https://europepmc.org/articles/pmc5501956?pdf=renderCitation Count: 21
-
OPENTitle: A sensitive assay reveals structural requirements for α-synuclein fibril growthJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 292Issue #: 22Start Page: 9034End Page: 9050Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.m116.767053Best OA location URL: http://www.jbc.org/article/S0021925820427061/pdfCitation Count: 24
- Falls in people with Parkinson’s disease: A prospective comparison of community and home-based falls2017RESTRICTEDTitle: Falls in people with Parkinson’s disease: A prospective comparison of community and home-based fallsJournal Name: Gait & PosturePublisher: Elsevier BVVol: 55Issue #:Start Page: 62End Page: 67Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.gaitpost.2017.04.005Citation Count: 39
-
RESTRICTEDTitle: Media hype: Patient and scientific perspectives on misleading medical newsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1319End Page: 1323Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26993Citation Count: 41
-
RESTRICTEDTitle: The Unfolded Protein Response: At the Intersection between Endoplasmic Reticulum Function and Mitochondrial BioenergeticsJournal Name: Frontiers in OncologyPublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fonc.2017.00055Best OA location URL: https://www.frontiersin.org/articles/10.3389/fonc.2017.00055/pdfCitation Count: 39
-
OPENTitle: Methamphetamine‐induced mitochondrial oxidant stress mediated by monoamine oxidase metabolism of dopamineJournal Name: The FASEB JournalPublisher: WileyVol: 31Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fasebj.31.1_supplement.987.3Best OA location URL: https://doi.org/10.1096/fasebj.31.1_supplement.987.3Citation Count: 3
-
OPENTitle: Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron lossJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 60Issue #:Start Page: 99End Page: 106Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2017.03.008Best OA location URL: https://europepmc.org/articles/pmc5499677?pdf=renderCitation Count: 43
-
RESTRICTEDTitle: Validation of Electrochemiluminescence Assays for Highly Sensitive and Reproducible Quantification of α-Synuclein in Cerebrospinal FluidJournal Name: BioanalysisPublisher: Informa UK LimitedVol: 9Issue #: 8Start Page: 621End Page: 630Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.4155/bio-2017-0005Citation Count: 11
-
OPENTitle: Parkinson disease in Gaucher diseaseJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-017-0054-2Best OA location URL: https://doi.org/10.1186/s40734-017-0054-2Citation Count: 13
-
RESTRICTEDTitle: Thalamic DBS with a constant-current device in essential tremor: A controlled clinical trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 40Issue #:Start Page: 18End Page: 26Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.03.017Citation Count: 64
- Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease2017RESTRICTEDTitle: Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 6Start Page: 893End Page: 903Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26976Citation Count: 32
-
OPENTitle: The Systemic Synuclein Sampling Study: Toward a Biomarker for Parkinson’s DiseaseJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 11Issue #: 4Start Page: 359End Page: 368Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2217/bmm-2016-0366Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/bmm-2016-0366Citation Count: 52
-
RESTRICTEDTitle: The prodromal phase of leucine‐rich repeat kinase 2–associated Parkinson disease: Clinical and imaging StudiesJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 5Start Page: 726End Page: 738Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26964Citation Count: 58
-
OPENTitle: Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 114Issue #: 15Start Page: 3999End Page: 4004Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1616874114Best OA location URL: https://www.pnas.org/content/pnas/114/15/3999.full.pdfCitation Count: 73
-
OPENTitle: Kinetin Riboside and Its ProTides Activate the Parkinson’s Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial DepolarizationJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 60Issue #: 8Start Page: 3518End Page: 3524Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acs.jmedchem.6b01897Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b01897Citation Count: 84
-
OPENTitle: Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analysesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-017-0012-6Best OA location URL: https://www.nature.com/articles/s41531-017-0012-6.pdfCitation Count: 34
-
OPENTitle: LRRK2 levels in immune cells are increased in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-017-0010-8Best OA location URL: https://doi.org/10.1038/s41531-017-0010-8Citation Count: 231
-
OPENTitle: The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK2Journal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 474Issue #: 9Start Page: 1547End Page: 1558Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1042/bcj20160909Best OA location URL: https://europepmc.org/articles/pmc6178381?pdf=renderCitation Count: 34
-
OPENTitle: An alpha‐synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progressionJournal Name: PROTEOMICS – Clinical ApplicationsPublisher: WileyVol: 11Issue #: 7-8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/prca.201700045Best OA location URL: https://europepmc.org/articles/pmc5540649?pdf=renderCitation Count: 19